GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyxone AB (OSTO:CYXO) » Definitions » Purchase Of Business

Cyxone AB (OSTO:CYXO) Purchase Of Business : kr0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Cyxone AB Purchase Of Business?

Cyxone AB's purchase of business for the three months ended in Jun. 2024 was kr0.00 Mil. It means Cyxone AB spent kr0.00 Mil on purchasing business. Cyxone AB's purchase of business for the trailing twelve months (TTM) ended in Jun. 2024 was kr0.00 Mil.

Compared with last quarter (kr0.00 Mil in Mar. 2024 ), Cyxone AB spent the same money on purchasing business in Jun. 2024 (kr0.00 Mil).


Cyxone AB Purchase Of Business Historical Data

The historical data trend for Cyxone AB's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyxone AB Purchase Of Business Chart

Cyxone AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only -0.96 - - - -

Cyxone AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cyxone AB Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cyxone AB Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Cyxone AB's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyxone AB Business Description

Traded in Other Exchanges
Address
Hyllie Boulevard 34, Malmo, SWE, 215 32
Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). The product candidates of the company include T20K and Rabeximod.

Cyxone AB Headlines

No Headlines